AXRX OTC
Amexdrug Corporation
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -99.9%
5Y: -99.6%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$3M
-14.6% ▼
5Y CAGR: -17.8%
Gross Profit
$1M
+6.9% ▲
5Y CAGR: -5.0%
Operating Income
$137K
+13.9% ▲
5Y CAGR: -13.4%
Net Income
$40K
+252.2% ▲
5Y CAGR: -28.6%
EPS (Diluted)
$0.00
+100.0% ▲
5Y CAGR: -31.2%
EBITDA
$137K
+13.9% ▲
5Y CAGR: -13.4%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $6M | $5M | $4M | $3M | $3M |
| YoY Growth | -17.6% | -24.3% | +0.0% | -13.2% | -14.6% |
| Cost of Revenue | $5M | $4M | $3M | $2M | $2M |
| Gross Profit | $2M | $995K | $1M | $1M | $1M |
| Gross Margin | 24.4% | 20.6% | 26.4% | 31.6% | 39.6% |
| R&D Expenses | $18K | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1M | $780K | $878K | $926K | $965K |
| Operating Expenses | $1M | $859K | $918K | $955K | $1M |
| Operating Income | $315K | $136K | $117K | $120K | $137K |
| Operating Margin | 4.9% | 2.8% | 3.0% | 3.5% | 4.7% |
| Interest Expense | $119K | $58K | $81K | $109K | $97K |
| Income Before Tax | $196K | $74K | $36K | $11K | $40K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | $196K | $74K | $36K | $11K | $40K |
| Net Margin | 3.1% | 1.5% | 0.9% | 0.3% | 1.4% |
| EPS (Diluted) | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 |
| EBITDA | $521K | $369K | $117K | $120K | $137K |
| Shares Outstanding | 169M | 169M | 169M | 169M | 169M |